丽珠得乐、果胶铋治疗溃疡病成本效果分析  

Cost-effectiveness Analysis of Treatments for Duodenal Ulcer by Livzon Dele and Colloidal Bismuth Pectin

作　　者：冯新生 

机构地区：[1]河南省直属机关第二医院,郑州市450003

出　　处：《医药论坛杂志》2003年第11期16-16,18,共2页Journal of Medical Forum

摘　　要：目的 探讨两种铋制治疗十二指肠溃疡(DU)的疗效和其经济效果。方法 DU患者84例,随机分成A、B两组,A组用丽珠得乐胶囊、雷尼替丁胶囊及阿莫西林胶囊联合治疗,B组给予胶体果胶铋胶囊、雷尼替下胶囊及阿莫西林胶囊联合治疗,运用药物经济学中的成本—效果分析法进行比较。结果 A、B两组总有效率分别为83.3％、85.7％,无明显差异(P>0.05),但治疗成本却有明显差异,A组成本较低。结论 药物经济学在指导临床合理用药、减轻患者经济负担方面具有重要意义。Objective Inquiring into therapeutic and economic effect of two bismuth preparations for duodenal ulcer(DU). Methods Patients of DU are 84, they are randomly divided into two groups of A and B. Patients of A are jointly cured by Livzcn dele capsules,Ranitidine hydrochloride capsules and Amoxicillin capsules, patiensts of B are jointly cured by Colloidal bismuth pectin capsules, Ranitidine hydrochloride capsules and Amoxicillin capsules, using the cost-effectiveness analysis methods of pharmaceutical economics to compare them. Results The efficient of A is 83. 3%, B is 85. 7%. There's no great difference( P >0. 05) ,but it shows a difference in treatment fee. The cost of A is low. Conclusion Pharmaceutical economics has an important function in indicating the clinical rational medication and lightening the economic burden on patients.

关 键 词：丽珠得乐 果胶铋 治疗 溃疡病 成本效果分析 

分 类 号：R573.1[医药卫生—消化系统]